Charles Explorer logo
🇬🇧

Hodgkin's lymphoma therapy results with a view to the treatment of relapses and primary progression

Publication at First Faculty of Medicine |
2005

Abstract

Between January 1996 and September 2004, 128 adult patients with Hodgkin?s lymphoma were treated at the Department of Clinical Haematology in Hradec Kralove. The group included 62 males and 66 females with median age 30 years (range, 17?74).

Primotherapy of choice was chemotherapy alone (29 %), chemotherapy and radiotherapy (69.5 %) and radiotherapy alone (1.5 %). All patients (n = 128) and group of patients with primary progression and/or relapse (n = 29) were evaluated retrospectively.

The median of the follow up was 41 months (range, 4?107). For survival analysis, Kaplan-Meier method was used, significance was tested using the logrank test.